Feed Preview

Acute Myeloid Leukaemia & RNA

Acute myeloid leukaemia (AML) is a common hematological type of cancer. As the population ages, there has been a rise in the frequency of AML. RNA expression has been used to see if there are different genetic profiles that exist within AML and whether these may underpin the variations in survival rates. Here is the latest research on AML and RNA.

Top 20 most recent papers

Clinical and functional significance of circular RNAs in cytogenetically normal AML

Blood AdvancesJanuary 17, 2020

Dimitrios PapaioannouRamiro Garzon

Publisher Correction: The long non-coding RNA HOXB-AS3 regulates ribosomal RNA transcription in NPM1-mutated acute myeloid leukemia

Nature CommunicationsJanuary 9, 2020

Dimitrios PapaioannouRamiro Garzon

Finding a suitable library size to call variants in RNA-seq

bioRxivDecember 19, 2019

Anna QuaglieriIan J Majewski

Ribosome biogenesis is a downstream effector of the oncogenic U2AF1-S34F mutation

bioRxivDecember 14, 2019

Abdalla AkefDaniel R. Larson

Insights into the involvement of spliceosomal mutations in myelodysplastic disorders from an analysis of SACY-1/DDX41 in Caenorhabditis elegans

bioRxivDecember 23, 2019

Tatsuya TsukamotoDavid Greenstein

Correction: The acetyltransferase GCN5 maintains ATRA-resistance in non-APL AML

LeukemiaJanuary 18, 2020

Melanie KahlTino Schenk

CBFβ-SMMHC Affects Genome-wide Polycomb Repressive Complex 1 Activity in Acute Myeloid Leukemia

Cell ReportsJanuary 16, 2020

Gaëlle CordonnierJonathan Bond

RNA splicing alterations induce a cellular stress response associated with poor prognosis in AML

bioRxivJanuary 11, 2020

Govardhan AnandeJohn E. Pimanda

Allogeneic hemopoietic stem cell transplants in patients with acute myeloid leukemia (AML) prepared with Busulfan Fludarabine (BUFLU) or Thiotepa Busulfan Fludarabine (TBF): a retrospective study

Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow TransplantationDecember 26, 2019

Federica SoraAndrea Bacigalupo

Long noncoding RNA UCA1 promotes autophagy by targeting miR-96-5p in acute myeloid leukemia

Clinical and Experimental Pharmacology & PhysiologyJanuary 19, 2020

Jia Jia LiJing Jing Zhang

In silico analysis of the prognostic value of FAS mRNA in malignancies

Journal of CancerJanuary 17, 2020

Zhigang ChenKe Wang

E2F4 functions as a tumour suppressor in acute myeloid leukaemia via inhibition of the MAPK signalling pathway by binding to EZH2

Journal of Cellular and Molecular MedicineJanuary 17, 2020

Yubin FengFeihu Chen

Prognostic and therapeutic relevance of cathepsin B in pediatric acute myeloid leukemia

American Journal of Cancer ResearchJanuary 9, 2020

Garima PandeyShyam S Chauhan

Increased Risk of Acute Myelogenous Leukemia After Early Onset but Not Late-Onset Colorectal Cancer

American Journal of Clinical OncologyDecember 27, 2019

Steven Lehrer, Peter H Rheinstein

The Solute Carrier Family 2 Genes Are Potential Prognostic Biomarkers in Acute Myeloid Leukemia

Technology in Cancer Research & TreatmentJanuary 11, 2020

Binbin LaiGuifang OuYang

MicroRNAs: pivotal regulators in acute myeloid leukemia

Annals of HematologyJanuary 15, 2020

Mingyu LiHongzai Guan

Upregulation of lncRNA CCAT2 predicts poor prognosis in patients with acute myeloid leukemia and is correlated with leukemic cell proliferation

International Journal of Clinical and Experimental PathologyJanuary 18, 2020

Jia-Jia LiJing-Jing Zhang

Neoantigens in Hematological Malignancies-Ultimate Targets for Immunotherapy?

Frontiers in ImmunologyJanuary 11, 2020

Malte RoerdenJuliane S Walz

A novel circular RNA (hsa_circ_0000370) increases cell viability and inhibits apoptosis of FLT3-ITD-positive acute myeloid leukemia cells by regulating miR-1299 and S100A7A

Biomedicine & Pharmacotherapy = Biomédecine & PharmacothérapieJanuary 11, 2020

Lingyan ZhangYan Wang

The long non-coding RNA Cancer Susceptibility 15 is induced by Isocitrate Dehydrogenase mutations and maintains an immature phenotype in adult acute myeloid leukemia

HaematologicaJanuary 4, 2020

Sarah GrasedieckFlorian Kuchenbauer

See more papers from this feed

Related Feeds

AAV-based Gene Therapy

Adeno-associated virus (AAV)-based gene therapy is a biological vector that is being researched to be used as a potential therapeutic option. This gene therapy is designed to insert fragments of DNA into targeted cells to help treat diseases, such as hemophilia a. Discover the latest research on AAV-based gene therapy here.

ALS: Genetics

Amyotrophic lateral sclerosis (ALS) is a progressive neurodegenerative disorder characterized by muscle weakness. ALS is a genetically heterogeneous disorder with several causative genes. Here are the latest discoveries pertaining to the genetics of this disease.

Acute Myeloid Leukemia

Acute myeloid leukemia (AML) is a clinically and genetically heterogeneous disease with approximately 20,000 cases per year in the United States. AML also accounts for 15-20% of all childhood acute leukemias, while it is responsible for more than half of the leukemic deaths in these patients. Here is the latest research on this disease.

Alzheimer's Disease: Genetics

Alzheimer's disease is a chronic neurodegenerative disease. Discover genetic and epigenetic aspects of Alzheimer’s disease, including genetic markers and genomic structural variations here.

Antisense Oligonucleotides: ND

This feed focuses on antisense oligonucleotide therapies such as Inotersen, Nusinursen, and Patisiran, in neurodegenerative diseases including amyotrophic lateral sclerosis.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Autoimmune Lymphoproliferative Syndrome

Autoimmune lymphoproliferative syndrome (ALPS) is a rare genetic disorder of abnormal lymphocyte survival caused by defective Fas mediated apoptosis. Discover the latest research on ALPS here.

B-Cell Lymphoma

B-cell lymphomas include lymphomas that affect B cells. This subtype of cancer accounts for over 80% of non-Hodgkin lymphomas in the US. Here is the latest research.

Birth Defects

Birth defects encompass structural and functional alterations that occur during embryonic or fetal development and are present since birth. The cause may be genetic, environmental or unknown and can result in physical and/or mental impairment. Here is the latest research on birth defects.

Blood And Marrow Transplantation

The use of hematopoietic stem cell transplantation or blood and marrow transplantation (bmt) is on the increase worldwide. BMT is used to replace damaged or destroyed bone marrow with healthy bone marrow stem cells. Here is the latest research on bone and marrow transplantation.

Contact Help Terms Privacy Cookies